BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 28099942)

  • 1. Bigh3 silencing increases retinoblastoma tumor growth in the murine SV40-TAg-Rb model.
    Allaman-Pillet N; Oberson A; Schorderet DF
    Oncotarget; 2017 Feb; 8(9):15490-15506. PubMed ID: 28099942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tgfbi/Bigh3 silencing activates ERK in mouse retina.
    Allaman-Pillet N; Oberson A; Bustamante M; Tasinato A; Hummler E; Schorderet DF
    Exp Eye Res; 2015 Nov; 140():159-170. PubMed ID: 26387839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of p75 neurotrophin receptor expression accompanies malignant progression to human and murine retinoblastoma.
    Dimaras H; Coburn B; Pajovic S; Gallie BL
    Mol Carcinog; 2006 May; 45(5):333-43. PubMed ID: 16555252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TAg-RB murine retinoblastoma cell of origin has immunohistochemical features of differentiated Muller glia with progenitor properties.
    Pajovic S; Corson TW; Spencer C; Dimaras H; Orlic-Milacic M; Marchong MN; To KH; Thériault B; Auspitz M; Gallie BL
    Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7618-24. PubMed ID: 21862643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple genetic loci modify risk for retinoblastoma in transgenic mice.
    Griep AE; Krawcek J; Lee D; Liem A; Albert DM; Carabeo R; Drinkwater N; McCall M; Sattler C; Lasudry JG; Lambert PF
    Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2723-32. PubMed ID: 9856783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of Id2 potentiates the tumorigenic effect of Rb inactivation in a mouse model of retinoblastoma.
    Landreville S; Ma D; Wu J; Harbour JW
    Curr Eye Res; 2010 May; 35(5):435-9. PubMed ID: 20450257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BIGH3 protein and macrophages in retinal endothelial cell apoptosis.
    Mondragon AA; Betts-Obregon BS; Moritz RJ; Parvathaneni K; Navarro MM; Kim HS; Lee CF; LeBaron RG; Asmis R; Tsin AT
    Apoptosis; 2015 Jan; 20(1):29-37. PubMed ID: 25378215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic instability and proliferation/survival pathways in RB1-deficient malignancies.
    Pappas L; Xu XL; Abramson DH; Jhanwar SC
    Adv Biol Regul; 2017 May; 64():20-32. PubMed ID: 28242412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The RB protein family in retinal development and retinoblastoma: new insights from new mouse models.
    Bremner R; Chen D; Pacal M; Livne-Bar I; Agochiya M
    Dev Neurosci; 2004; 26(5-6):417-34. PubMed ID: 15855771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells.
    Dalgard CL; Gonzalez M; deNiro JE; O'Brien JM
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4542-51. PubMed ID: 19443717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental stage-specific proliferation and retinoblastoma genesis in RB-deficient human but not mouse cone precursors.
    Singh HP; Wang S; Stachelek K; Lee S; Reid MW; Thornton ME; Craft CM; Grubbs BH; Cobrinik D
    Proc Natl Acad Sci U S A; 2018 Oct; 115(40):E9391-E9400. PubMed ID: 30213853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The p75 NTR neurotrophin receptor is a tumor suppressor in human and murine retinoblastoma development.
    Dimaras H; Gallie BL
    Int J Cancer; 2008 May; 122(9):2023-9. PubMed ID: 18196575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperation between Rb and Arf in suppressing mouse retinoblastoma.
    Conkrite K; Sundby M; Mu D; Mukai S; MacPherson D
    J Clin Invest; 2012 May; 122(5):1726-33. PubMed ID: 22484813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AP2 transcription factor induces apoptosis in retinoblastoma cells.
    Li X; Glubrecht DD; Godbout R
    Genes Chromosomes Cancer; 2010 Sep; 49(9):819-30. PubMed ID: 20607706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentiviral vector-mediated PAX6 overexpression promotes growth and inhibits apoptosis of human retinoblastoma cells.
    Li L; Li B; Zhang H; Bai S; Wang Y; Zhao B; Jonas JB
    Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8393-400. PubMed ID: 21948554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein.
    Paramio JM; Navarro M; Segrelles C; Gómez-Casero E; Jorcano JL
    Oncogene; 1999 Dec; 18(52):7462-8. PubMed ID: 10602505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kif14 overexpression accelerates murine retinoblastoma development.
    O'Hare M; Shadmand M; Sulaiman RS; Sishtla K; Sakisaka T; Corson TW
    Int J Cancer; 2016 Oct; 139(8):1752-8. PubMed ID: 27270502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microarray analysis and biochemical correlations of oxidative stress responsive genes in retinoblastoma.
    Vandhana S; Lakshmi TS; Indra D; Deepa PR; Krishnakumar S
    Curr Eye Res; 2012 Sep; 37(9):830-41. PubMed ID: 22668346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trichostatin A-induced TGF-beta type II receptor expression in retinoblastoma cell lines.
    Kashiwagi Y; Horie K; Kanno C; Inomata M; Imamura T; Kato M; Yamamoto T; Yamashita H
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):679-85. PubMed ID: 19737884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutically inhibiting polo-like kinase 1 exerts a broad anti-tumour activity in retinoblastoma cell lines.
    Schwermer M; Dreesmann S; Eggert A; Althoff K; Steenpass L; Schramm A; Schulte JH; Temming P
    Clin Exp Ophthalmol; 2017 Apr; 45(3):288-296. PubMed ID: 27647547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.